Her2/neu expression in breast cancer CNS metastases is highly concordant with systemic disease status, with 93% of patients with Her2/neu positive primary tumors also expressing Her2/neu in CNS metastatic disease [18]. This evidence concerns the gene ERBB2 and metastatic neoplasm.